The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for A-M Systems sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
A-M Systems is a medical device company that designs, manufactures, and distributes biomedical and neuroscience research equipment. The company offers a range of products, including amplifiers, electrodes, syringe pumps, and respiratory measurement tools. It engages in two divisions to deliver respiratory care products and precision neurophysiology instruments. The company designs and develops pulmonary and respiratory care products, including VBMax (test filters), ViroMax (viral-bacterial filter), HydroMax (HME filter) the popular; and neurophysiology scientific instruments, including intra- and extracellular amplifiers, stimulators, and patch clamps. A-M Systems is headquartered in Carlsborg, Washington, the US.
The key metrics of A-M Systems related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As A-M Systems is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as A-M Systems.
For a detailed understanding of the performance of A-M Systems, buy the report here.